Biofil Chemicals & Pharmaceuticals Ltd

Biofil Chemicals Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Biofil Chemicals & Pharmaceuticals Ltd

₹ 45.2 3.37%
04 Aug - close price
biofilgroup.net BSE: 524396 NSE: BIOFILCHEM
About

Incorporated in 1993, Biofil Chemicals and Pharmaceuticals Ltd manufactures pharmaceutical bulk drugs[1]

Key Points

Business Overview:[1][2]
Company deals in manufacturing and trading of pharmaceutical and also manufactures plastic products required for packing pharmaceutical and other plastic products. Further, it also deals in providing job work facility in respect of manufacturing of pharmaceuticals drugs via 2 units viz. Pharmaceutical Division & Chemicals Division.

Website BSE NSE - BE
  • Market Cap ₹ 73.5 Cr.
  • Current Price ₹ 45.2
  • High / Low ₹ 92.0 / 40.4
  • Stock P/E 131
  • Book Value ₹ 11.5
  • Dividend Yield 0.00 %
  • ROCE 4.12 %
  • ROE 3.03 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter

Cons

  • Stock is trading at 3.91 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 2.38% over past five years.
  • Company has a low return on equity of 3.43% over last 3 years.
  • Earnings include an other income of Rs.0.31 Cr.
  • Company has high debtors of 419 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
1.65 12.31 2.62 1.49 13.62 2.43 17.37 5.03 15.20 8.44 2.41 14.20 8.35
1.51 11.94 2.46 1.26 13.21 2.01 17.13 4.84 15.24 8.13 2.29 13.89 8.24
Operating Profit 0.14 0.37 0.16 0.23 0.41 0.42 0.24 0.19 -0.04 0.31 0.12 0.31 0.11
OPM % 8.48% 3.01% 6.11% 15.44% 3.01% 17.28% 1.38% 3.78% -0.26% 3.67% 4.98% 2.18% 1.32%
0.03 0.02 0.02 0.02 0.03 0.02 0.03 0.03 0.41 0.03 0.02 0.02 0.24
Interest 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.02 0.01 0.01 0.01 0.01
Depreciation 0.12 0.11 0.11 0.11 0.11 0.11 0.11 0.11 0.08 0.10 0.10 0.10 0.08
Profit before tax 0.04 0.27 0.06 0.13 0.32 0.32 0.15 0.11 0.27 0.23 0.03 0.22 0.26
Tax % 200.00% 25.93% 33.33% 23.08% 34.38% 25.00% 20.00% 18.18% 11.11% 26.09% 33.33% 27.27% 23.08%
-0.03 0.21 0.05 0.10 0.21 0.24 0.12 0.09 0.25 0.17 0.02 0.16 0.20
EPS in Rs -0.02 0.13 0.03 0.06 0.13 0.15 0.07 0.06 0.15 0.10 0.01 0.10 0.12
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
7.17 5.86 13.17 13.45 12.36 23.13 29.69 35.75 22.38 30.04 40.04 33.40
6.21 5.12 12.30 10.84 11.43 22.11 27.87 34.15 21.05 28.88 39.23 32.55
Operating Profit 0.96 0.74 0.87 2.61 0.93 1.02 1.82 1.60 1.33 1.16 0.81 0.85
OPM % 13.39% 12.63% 6.61% 19.41% 7.52% 4.41% 6.13% 4.48% 5.94% 3.86% 2.02% 2.54%
0.06 0.46 0.53 0.14 0.10 0.10 0.17 0.80 0.15 0.10 0.49 0.31
Interest 0.15 0.21 0.15 0.16 0.15 0.16 0.12 0.07 0.04 0.04 0.04 0.04
Depreciation 0.22 0.25 0.26 0.28 0.30 0.37 0.41 0.41 0.43 0.43 0.40 0.38
Profit before tax 0.65 0.74 0.99 2.31 0.58 0.59 1.46 1.92 1.01 0.79 0.86 0.74
Tax % 20.00% 20.27% 20.20% 22.51% 20.69% 20.34% 17.81% 34.90% 31.68% 29.11% 17.44% 24.32%
0.52 0.59 0.78 1.79 0.47 0.48 1.21 1.24 0.70 0.56 0.71 0.56
EPS in Rs 0.32 0.36 0.48 1.10 0.29 0.29 0.74 0.76 0.43 0.34 0.44 0.34
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: 19%
5 Years: 2%
3 Years: 14%
TTM: -17%
Compounded Profit Growth
10 Years: -1%
5 Years: -14%
3 Years: -7%
TTM: -21%
Stock Price CAGR
10 Years: 19%
5 Years: 15%
3 Years: -6%
1 Year: -28%
Return on Equity
10 Years: 6%
5 Years: 4%
3 Years: 3%
Last Year: 3%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 16.27 16.27 16.27 16.27 16.27 16.27 16.27 16.27 16.27 16.27 16.27 16.27
Reserves -8.41 -7.86 -5.37 -3.58 -3.11 -2.62 -1.39 -0.14 0.56 1.03 1.93 2.51
2.87 2.98 1.37 1.43 1.56 1.64 1.19 0.43 0.46 0.52 0.44 0.47
3.87 2.36 11.87 7.72 9.44 8.93 26.30 16.68 1.44 13.58 28.44 31.71
Total Liabilities 14.60 13.75 24.14 21.84 24.16 24.22 42.37 33.24 18.73 31.40 47.08 50.96
9.17 9.06 8.98 9.16 9.25 10.29 10.09 9.78 9.42 9.00 8.62 8.34
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
5.43 4.69 15.16 12.68 14.91 13.93 32.28 23.46 9.31 22.40 38.46 42.62
Total Assets 14.60 13.75 24.14 21.84 24.16 24.22 42.37 33.24 18.73 31.40 47.08 50.96

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.21 0.01 0.14 0.71 0.46 1.26 0.89 1.11 -0.22 -0.11 2.39 -1.92
-0.24 -0.17 -0.19 -0.48 -0.38 -1.41 -0.21 -0.10 -0.07 -0.01 -0.02 -0.10
0.07 0.11 0.10 -0.11 -0.02 -0.08 -0.57 -0.83 -0.01 0.02 -0.12 0.00
Net Cash Flow 0.04 -0.05 0.05 0.13 0.06 -0.24 0.12 0.18 -0.30 -0.11 2.25 -2.03

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 208.72 227.35 387.45 311.00 383.31 189.84 365.25 175.81 116.94 249.08 301.10 418.77
Inventory Days 20.53 15.99 3.46 7.29 38.11 21.73 24.37 48.85 24.20 16.11 24.81 39.53
Days Payable 276.79 198.49 400.98 304.52 341.46 156.66 373.80 178.39 11.25 168.39 268.08 366.78
Cash Conversion Cycle -47.54 44.85 -10.07 13.76 79.95 54.90 15.82 46.27 129.88 96.80 57.83 91.52
Working Capital Days -75.85 -47.96 48.50 87.65 104.83 50.81 55.69 64.12 125.25 104.25 69.37 114.09
ROCE % 7.66% 8.59% 9.64% 18.72% 5.06% 5.00% 10.08% 12.20% 6.20% 4.73% 4.94% 4.12%

Shareholding Pattern

Numbers in percentages

Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
46.82% 46.82% 46.82% 46.82% 46.82% 46.82% 46.82% 46.82% 46.82% 46.82% 46.82% 46.82%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.03% 0.00% 0.00% 0.00% 0.00% 0.00%
0.08% 0.08% 0.08% 0.08% 0.08% 0.08% 0.08% 0.08% 0.08% 0.08% 0.08% 0.08%
53.09% 53.10% 53.11% 53.10% 53.10% 53.11% 53.08% 53.11% 53.10% 53.11% 53.11% 53.10%
No. of Shareholders 28,25728,37827,47526,74126,12325,86426,58125,48026,42226,11425,91425,685

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports